NeXstar, Becton, Dickinson deal

NXTR and Becton, Dickinson redefined the terms of their May 1993 agreement to develop in vitro diagnostic reagents using NXTR's SELEX combinatorial chemistry process. NXTR asked for the amendments so it could pursue diagnostic applications of the SELEX process outside of B-D's focus. ...